Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Genelux Corporation
Genelux Corporation
Merck Sharp & Dohme LLC
AstraZeneca
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
BioNTech SE
ImmunityBio, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Laekna Limited
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
Inspirna, Inc.
Eli Lilly and Company
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Merck Sharp & Dohme LLC
Azaya Therapeutics, Inc.
Sanofi
Sanofi
Sanofi
Sanofi